Ono Pharmaceutical Co., Ltd

(OTCGREY:OPHLF)

Latest On Ono Pharmaceutical Co., Ltd (OPHLF):

Date/Time Type Description Signal Details
2021-03-30 06:07 ESTDividendA dividend of $22.5 has been announced on May 12, 2020. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 30, 2021.Neutral
2021-02-10 23:29 ESTNewsBristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancerN/A
2021-02-04 09:26 ESTFinancialsCompany financials have been released.Neutral
2021-02-02 13:45 ESTEarnings EstimateAn EPS average of $43.10 is estimated for the quarter ending on June 30, 2021.Sell
2020-11-26 23:00 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 02:02 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:25 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 09:42 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:16 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:19 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:54 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-03 10:26 ESTEarnings EstimateAn EPS average of $0.34 is estimated for the quarter ending on December 31, 2020.Sell
2020-08-02 06:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:03 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-08 10:16 ESTEarnings EstimateAn EPS average of $31.40 is estimated for the quarter ending on September 30, 2020.Buy
2020-07-01 18:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:38 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:44 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:50 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:25 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 10:23 ESTEarnings EstimateAn EPS average of $1.40 is estimated for the 2022 year.Buy
2020-05-27 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-05-23 22:18 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 03:05 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:44 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:39 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:27 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:33 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 23:02 ESTFinancialsCompany financials have been released.Neutral
2020-03-30 06:09 ESTDividendA dividend of $22.5 has been announced on May 9, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Mar 30, 2020.Neutral
2020-03-25 22:33 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 06:06 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 00:09 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:41 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:41 ESTEarningsEarnings have been released on March 31, 2019, with $0.15 earnings per share.Sell
2020-02-22 01:41 ESTEarnings EstimateAn EPS average of $0.31 is estimated for the quarter ending on June 30, 2020.Sell
2020-02-22 01:41 ESTEarningsEarnings have been released on December 31, 2019, with $0.35 earnings per share.Buy
2020-02-22 01:41 ESTEarningsEarnings have been released on September 30, 2019, with $0.30 earnings per share.Buy
2020-02-22 01:41 ESTEarningsEarnings have been released on June 30, 2019, with $0.30 earnings per share.Buy
2020-02-21 01:11 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:27 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:41 ESTFinancialsCompany financials have been released.Neutral
2020-02-10 15:39 ESTEarningsEarnings have been released on December 31, 2016, with $0.34 earnings per share.Sell

About Ono Pharmaceutical Co., Ltd (OPHLF):

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER Capsule for improvement of the symptoms in patients with pheochromocytoma; and BRAFTOVI capsules, and MEKTOVI and VELEXBRU tablets for malignant tumors. It also provides GLACTIV and FORXIGA tablets for type 2 diabetes; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; PARSABIV, an intravenous injection for dialysis patients; ONOACT injections for tachyarrhythmia; STAYBLA tablets for overactive bladder; OPALMON tablets to treat peripheral circulatory disorder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; CORALAN for treatment of chronic heart failure; and RECALBON tablets for osteoporosis. In addition, the company is developing products for colorectal, esophageal, gastric or esophago-gastric junction, small and non-small cell lung, ovarian, pancreatic, prostate, biliary tract, hematologic, and head and neck cancers; hepatocellular, urothelial, and virus positive/negative solid carcinoma; glioblastoma; multiple myeloma; malignant pleural mesothelioma; solid tumors; central nervous system, primary testicular, and lymphoplasmacytic; acute myeloid leukemia; melanoma; primary macroglobulinemia; chronic heart failure; Parkinson's disease; structural damage of the joints in rheumatoid arthritis; polymyositis/dermatomyositis; osteoarthritis; enthesopathy; pemphigus; celebral infarction; acromegaly; thrombosis; and autoimmune disease. The company has research and option agreement with Numab Therapeutics AG. Ono Pharmaceutical Co., Ltd. was founded in 1717 and is headquartered in Osaka, Japan.

See Advanced Chart

General

  • Name Ono Pharmaceutical Co., Ltd
  • Symbol OPHLF
  • Type Common Stock
  • Exchange OTCGREY
  • Currency USD
  • Country USA
  • Full Time Employees 3,560
  • Fiscal Year EndMarch
  • Web URLhttp://www.ono.co.jp
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $148.77
  • Next Year EPS Estimate $175.05
  • Next Quarter EPS Estimate $0.25
  • Profit Margin 25%
  • Return on Assets 9%
  • Return on Equity 12%
  • Revenue Per Share $0
  • Gross Profit 213.36 billion
  • Quarterly Earnings Growth 10.7%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 35.19
  • Environment Score 4.67
  • Social Score 19.89
  • Governance Score 17.14
  • Controversy Level 1
View More

Highlights

  • Market Capitalization 15.18 billion
  • PEG Ratio 40586.9
View More

Share Statistics

  • Shares Outstanding 514.12 million
  • Shares Float 464.86 million
  • % Held by Insiders 1792%
  • % Held by Institutions 33.81%
View More

Technicals

  • Beta 0.48
  • 52 Week High $31
  • 52 Week Low $18
  • 50 Day Moving Average 29.26
  • 200 Day Moving Average 28.37
View More

Dividends

  • Dividend Date 2018-06-25
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ono Pharmaceutical Co., Ltd (OPHLF) Dividend Calendar:

OPHLF's last dividend payment was made to shareholders on June 25, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ono Pharmaceutical Co., Ltd (OPHLF) Earnings Estimates:

An earnings estimate is an analyst's estimate for a company's future quarterly or annual earnings per share (EPS). Future earnings estimates are arguably the most important data when attempting to value a firm.

OPHLF's EPS estimate for the current year is $148.77
Date Number of Analysts Average Estimate Low Estimate High Estimate
2021-06-301$43.10$43.10$43.10

Ono Pharmaceutical Co., Ltd (OPHLF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

OPHLF's next estimated earnings release date is June 30, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A$53.37$32.8162.66%
2020-09-302020-12-31$N/A$0.52$31.40-98.35%
2020-06-302020-09-30$N/A$0.35$35.40-99.02%
2020-03-312020-06-30$N/A$0.40$17.21-97.68%
2019-12-312020-03-31$702.33 million$0.15$29.14-99.5%
2019-09-302019-12-31$694.17 million$0.35$26.29-98.67%
2019-06-302019-09-30$683.25 million$0.30$27.20-98.89%
2019-03-312019-06-30$587.64 million$0.30$18.20-98.38%
2018-12-312019-03-31$719.16 million$0.15$36.20-99.59%
2018-09-302018-12-31$642.12 million$0.25$25.80-99.02%
2018-06-302018-09-30$642.43 million$0.23$27.80-99.16%
2018-03-312018-06-30$578.55 million$0.27$7.80-96.57%
2017-12-312018-03-31$702.37 million$0.16$24.80-99.35%
2017-09-302017-12-31$536.81 million$0.35$15.00-97.67%
2017-06-302017-09-30$542.03 million$0.16$21.30-99.24%
2017-03-312017-06-30$55.95 billion$0.20
2016-12-312017-03-31$0.23$51.10-99.56%
2016-09-302016-12-31$0.31$21.90-98.57%
2016-06-302016-09-30$0.18$26.60-99.34%
2016-03-312016-06-30$0.25$7.20-96.51%
2015-12-312016-03-31$0.10$5.68-98.29%
2015-09-302015-12-31$0.11$0.00
2015-06-302015-09-30$0.04$0.00
2015-03-312015-06-30$0.15$0.00
2014-12-312015-03-31-$0.04$8.98-100.48%
2014-09-302014-12-31$0.20$1.06-81.54%
2014-06-302014-09-30$0.01$0.00
2014-03-312014-06-30$0.05$6.04-99.1%
2013-12-312014-03-31$0.04$0.00
2013-09-302013-12-31$0.15$0.00
2013-06-302013-09-30$0.07$0.00
2013-03-312013-06-30$0.12$0.00
2012-12-312013-03-31$0.13$0.00
2012-09-302012-12-31$0.14$0.00
2012-06-302012-09-30$0.06$0.00
2012-03-312012-06-30$0.20$0.00
2011-12-312012-03-31$0.15$0.00
2011-09-302011-12-31$0.23$0.00
2011-06-302011-09-30$0.00$0.00
2011-03-312011-06-30$0.20$0.00
2010-12-312011-03-31$0.12$0.00
2010-09-302010-12-31$0.22$0.00

Ono Pharmaceutical Co., Ltd (OPHLF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ono Pharmaceutical Co., Ltd (OPHLF) Chart:

Ono Pharmaceutical Co., Ltd (OPHLF) News:

Below you will find a list of latest news for Ono Pharmaceutical Co., Ltd (OPHLF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ono Pharmaceutical Co., Ltd (OPHLF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Ono Pharmaceutical Co., Ltd (OPHLF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2016-10-17F-6Registration of American Depository Receipt shares, not immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000095012716000087/0000950127-16-000087-index.htm
2017-04-26F-6/ARegistration of American Depository Receipt shares, not immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000095012717000017/0000950127-17-000017-index.htm
2017-05-22F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/940821/000095012717000026/0000950127-17-000026-index.htm
2008-10-31F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000101915508000735/0001019155-08-000735-index.htm
2014-05-23F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/940821/000101915514000206/0001019155-14-000206-index.htm
2016-05-24F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/940821/000101915516000592/0001019155-16-000592-index.htm
2008-10-10F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000110465908063300/0001104659-08-063300-index.htm
2009-02-20RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/940821/000115955409000005/0001159554-09-000005-index.htm
2015-07-24F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000119380515001248/0001193805-15-001248-index.htm
2016-03-30F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/940821/000119380516002953/0001193805-16-002953-index.htm
2016-08-25F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000119380516003823/0001193805-16-003823-index.htm
2017-09-29F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/940821/000119380517002942/0001193805-17-002942-index.htm
2019-11-22F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/940821/000119380519001593/0001193805-19-001593-index.htm
2017-04-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/940821/999999999517000962/9999999995-17-000962-index.htm